|
Colchicine 0.5 MG Oral Tablet Clinical Trials
2 actively recruiting trials across 1 location
Also known as: Colchicine
Pipeline
Phase 3: 2
Top Sponsors
- Population Health Research Institute1
- AZ Sint-Jan AV1
Indications
- Heart Disease2
- Atherosclerosis of Extremities1
- Coronary Artery Disease1
- Inflammation1
- Peripheral Arterial Disease1
Other1 trial
New Haven, Connecticut1 trial
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Yale School of Medicine
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.